LUMOS PHARMA, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Lumos Pharma, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2010 to Q3 2024.
  • Lumos Pharma, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$7.47M, a 10% increase year-over-year.
  • Lumos Pharma, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$34.9M, a 6.37% decline year-over-year.
  • Lumos Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$34M, a 9.57% decline from 2022.
  • Lumos Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$31.1M, a 2.08% decline from 2021.
  • Lumos Pharma, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$30.4M, a 437% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$34.9M -$7.47M +$833K +10% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$35.7M -$7.55M +$1.38M +15.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$37.1M -$10.4M -$3.1M -42.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$34M -$9.46M -$1.21M -14.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$32.8M -$8.3M -$1.05M -14.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$31.8M -$8.93M -$1.09M -13.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$30.7M -$7.35M +$374K +4.85% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$31.1M -$8.25M -$2.61M -46.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$28.5M -$7.25M +$237K +3.17% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$28.7M -$7.84M +$826K +9.53% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$29.5M -$7.72M +$911K +10.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$30.4M -$5.64M -$3.23M -134% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 -$27.2M -$7.49M -$9.25M -524% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$18M -$8.67M -$3.32M -62% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$14.6M -$8.63M -$8.97M -2639% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$5.66M -$2.42M +$5.86M +70.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$11.5M $1.77M +$4.43M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$16M -$5.35M -$2.78M -108% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-05
Q1 2020 -$13.2M $340K +$2.45M Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-05
Q4 2019 -$15.6M -$8.27M +$2.3M +21.7% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-03
Q3 2019 -$17.9M -$2.67M +$4.73M +63.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$22.6M -$2.57M +$14.7M +85.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-12
Q1 2019 -$37.4M -$2.11M +$16.2M +88.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-12
Q4 2018 -$53.6M -$10.6M +$3.12M +22.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$56.7M -$7.4M +$13.2M +64.1% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-03
Q2 2018 -$69.9M -$17.3M -$587K -3.51% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-03
Q1 2018 -$69.3M -$18.3M +$2.6M +12.4% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-03
Q4 2017 -$72M -$13.7M -$180K -1.33% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-05
Q3 2017 -$71.8M -$20.6M -$5.09M -32.7% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-05
Q2 2017 -$66.7M -$16.7M +$15.7M +48.4% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-05
Q1 2017 -$82.3M -$20.9M +$2.81M +11.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-05
Q4 2016 -$85.2M -$13.5M +$8.07M +37.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-05
Q3 2016 -$93.2M -$15.5M +$366K +2.3% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-05
Q2 2016 -$93.6M -$32.4M -$18.3M -130% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-05
Q1 2016 -$75.3M -$23.7M -$34.9M -312% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-05
Q4 2015 -$40.4M -$21.6M -$142M -118% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 $101M -$15.9M -$10.3M -184% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 $112M -$14.1M -$4.93M -53.8% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 $116M $11.2M +$20.4M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 $96M $120M +$128M Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 -$32M -$5.6M +$2.53M +31.1% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 -$34.6M -$9.16M -$2.09M -29.5% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 -$32.5M -$9.24M -$1.3M -16.4% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 -$31.2M -$8.05M -$1.73M -27.3% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$29.5M -$8.12M -$2.27M -38.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$27.2M -$7.08M -$768K -12.2% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$26.4M -$7.93M -$3.09M -63.9% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$23.3M -$6.32M -$509K -8.76% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-16
Q3 2012 -$22.8M -$5.85M -$1.87M -46.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$20.9M -$6.31M -$1.92M -43.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$19M -$4.84M -$945K -24.2% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q4 2011 -$18.1M -$5.81M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-12
Q3 2011 -$3.99M +$1.05M +20.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-31
Q2 2011 -$4.39M Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$3.9M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$5.03M Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-01-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.